BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 36425841)

  • 21. The impact of smart manufacturing demonstration projects on green innovation of Chinese firms: Based on random forest methods.
    Yang J; Wang W; Fu C; Xu X; Li Q
    Heliyon; 2024 Apr; 10(7):e28925. PubMed ID: 38596016
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does PM2.5 (Pollutant) Reduce Firms' Innovation Output?
    Xiong Z; Li D; Yu H
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36673867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Environmental regulation, firms' bargaining power, and firms' total factor productivity: evidence from China.
    Yang S; Wang C; Zhang H; Lu T; Yi Y
    Environ Sci Pollut Res Int; 2022 Feb; 29(6):9341-9353. PubMed ID: 34499302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unveiling the Effectiveness of Agency Cost and Firms' Size as Moderators Between CSR Disclosure and Firms' Growth.
    Akram A; Tang Y; Tariq J
    Front Psychol; 2020; 11():1624. PubMed ID: 32903572
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of environmental regulatory instruments on agribusiness technology innovation-A study of configuration effects based on fsQCA.
    Xia J; Zhang L; Song Y
    PLoS One; 2024; 19(1):e0294662. PubMed ID: 38236829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How Do Heterogeneous Networks Affect a Firm's Innovation Performance? A Research Analysis Based on Clustering and Classification.
    Zhang L; Qiu H; Chen J; Zhou W; Li H
    Entropy (Basel); 2023 Nov; 25(11):. PubMed ID: 37998252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Firm innovation activities and consumer brand loyalty: A path to business sustainability in Asia.
    Yi L; Khan MS; Safeer AA
    Front Psychol; 2022; 13():942048. PubMed ID: 35959050
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The moderating role of absorptive capacity and the differential effects of acquisitions and alliances on Big Pharma firms' innovation performance.
    Fernald KD; Pennings HP; van den Bosch JF; Commandeur HR; Claassen E
    PLoS One; 2017; 12(2):e0172488. PubMed ID: 28231332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Does the CEOs' hometown identity matter for firms' environmental, social, and governance (ESG) performance?
    Wang L; Zhang Y; Qi C
    Environ Sci Pollut Res Int; 2023 Jun; 30(26):69054-69063. PubMed ID: 37127738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Cooperative Innovation on the Technological Innovation Performance of High-Tech Firms: A Dual Moderating Effect Model of Big Data Capabilities and Policy Support.
    Li X; Wang Q; Shi R; Wang X; Zhang K; Liu X
    Big Data; 2024 Feb; 12(1):63-80. PubMed ID: 37707986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distance matters: Investigating how geographic proximity to ENGOs triggers green innovation of heavy-polluting firms in China.
    Hu C; Mao J; Tian M; Wei Y; Guo L; Wang Z
    J Environ Manage; 2021 Feb; 279():111542. PubMed ID: 33162234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. How can artificial intelligence boost firms' exports? evidence from China.
    Zhang Z; Deng F
    PLoS One; 2023; 18(8):e0283230. PubMed ID: 37611039
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How does capital structure change product-market competitiveness? Evidence from Chinese firms.
    Li L; Wang Z
    PLoS One; 2019; 14(2):e0210618. PubMed ID: 30721237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Turning inward in difficulties: R&D human resource slack, technological diversification, and independent innovation.
    Li H; Zhao Y; Li Y; Wang Y
    PLoS One; 2024; 19(6):e0298453. PubMed ID: 38870238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantity or quality? The impact of financial geo-density on firms' green innovation.
    Li S; Chen L; Xu P
    Environ Sci Pollut Res Int; 2023 Apr; 30(18):54073-54094. PubMed ID: 36869960
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gender diversity in European firms and the R&D-innovation-productivity nexus.
    Capozza C; Divella M
    J Technol Transf; 2023 Apr; ():1-22. PubMed ID: 37359815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The U-shaped impact of export quality on firms' innovation output: Empirical evidence from China.
    Cai Y; Wu G
    PLoS One; 2024; 19(2):e0298358. PubMed ID: 38394251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Managerial Myopia and Firm Green Innovation: Based on Text Analysis and Machine Learning.
    Liu X
    Front Psychol; 2022; 13():911335. PubMed ID: 35795435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Integrating green business strategies and green competencies to enhance green innovation: evidence from manufacturing firms of Pakistan.
    Yahya S; Khan A; Farooq M; Irfan M
    Environ Sci Pollut Res Int; 2022 Jun; 29(26):39500-39514. PubMed ID: 35103945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 'Guidance' or 'Misleading'? The government subsidy and the choice of enterprise innovation strategy.
    Ding J; Wang J; Liu B; Peng L
    Front Psychol; 2022; 13():1005563. PubMed ID: 36267081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.